NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock

$8.46-0.05 (-0.59%)
Updated Jan 24, 2022
TEVA Price
$8.46
Fair Value Price
N/A
Market Cap
$9.33B
52 Week Low
$7.73
52 Week High
$13.30
P/E
12.82x
P/B
0.89x
P/S
0.66x
PEG
0.21x
Dividend Yield
N/A
Revenue
$16.23B
Earnings
$726.00M
Gross Margin
46.8%
Operating Margin
12.41%
Profit Margin
4.5%
Debt to Equity
3.48
Operating Cash Flow
$673M
Beta
1.1
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

High
Medium
Low
Industry Average (21)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TEVA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TEVA ($8.46) is trading below its intrinsic value of $132.23, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
TEVA is good value based on its earnings relative to its share price (12.82x), compared to the US market average 34.17x)
Valuation
TEVA is good value based... subscribe to Premium to read more.
Valuation
There are 23 more TEVA due diligence checks available for Premium users.

TEVA News

Valuation

TEVA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
12.82x
Industry
131.02x
Market
34.17x
TEVA is good value based... subscribe to Premium to read more.
Valuation
TEVA is good value based... subscribe to Premium to read more.
Valuation

TEVA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.89x
Industry
2.15x
TEVA is good value based... subscribe to Premium to read more.
Valuation

TEVA price to earnings growth (PEG)

For valuing profitable companies with growth potential
TEVA is good value based... subscribe to Premium to read more.
Valuation

TEVA's financial health

Profit margin

Revenue
$3.9B
Net Income
$292.0M
Profit Margin
7.5%
TEVA's Earnings (EBIT) of $2.02B... subscribe to Premium to read more.
Financials
TEVA's profit margin has increased... subscribe to Premium to read more.
Financials

Assets to liabilities

Assets
$47.9B
Liabilities
$36.4B
Debt to equity
3.48
TEVA's short-term assets ($12.15B) exceed... subscribe to Premium to read more.
Financials
TEVA's long-term liabilities ($24.58B) exceed... subscribe to Premium to read more.
Financials
TEVA's debt to equity ratio... subscribe to Premium to read more.
Financials

Cash flow

Operating
$529.0M
Investing
$288.0M
Financing
-$1.2B
TEVA's operating cash flow ($673.00M)... subscribe to Premium to read more.
Financials

Teva Pharmaceutical Industries Ltd Stock FAQ

What is Teva Pharmaceutical Industries Ltd's quote symbol?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd trades on the NYSE under the ticker symbol TEVA. Teva Pharmaceutical Industries Ltd stock quotes can also be displayed as NYSE: TEVA.

What is the 52 week high and low for Teva Pharmaceutical Industries Ltd (NYSE: TEVA)?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's 52-week high was $13.30, and its 52-week low was $7.73. It is currently -36.39% from its 52-week high and 9.44% from its 52-week low.

How much is Teva Pharmaceutical Industries Ltd stock worth today?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd currently has 1,103,007,168 outstanding shares. With Teva Pharmaceutical Industries Ltd stock trading at $8.46 per share, the total value of Teva Pharmaceutical Industries Ltd stock (market capitalization) is $9.33B.

Teva Pharmaceutical Industries Ltd stock was originally listed at a price of $5.91 in Dec 31, 1997. If you had invested in Teva Pharmaceutical Industries Ltd stock at $5.91, your return over the last 24 years would have been 43.05%, for an annualized return of 1.5% (not including any dividends or dividend reinvestments).

How much is Teva Pharmaceutical Industries Ltd's stock price per share?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd stock price per share is $8.46 today (as of Jan 24, 2022).

What is Teva Pharmaceutical Industries Ltd's Market Cap?

(NYSE: TEVA) Teva Pharmaceutical Industries Ltd's market cap is $9.33B, as of Jan 25, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Teva Pharmaceutical Industries Ltd's market cap is calculated by multiplying TEVA's current stock price of $8.46 by TEVA's total outstanding shares of 1,103,007,168.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.